Preparation and Standardisation of Vaccines and Immunization

Introduction

  • Vaccination is one of the greatest achievements in modern medicine.
  • It has significantly reduced the incidence of many infectious diseases and has contributed to the eradication of smallpox and near-eradication of poliomyelitis in several parts of the world.
  • Vaccines work by stimulating the immune system to recognize and respond to specific pathogens before natural exposure occurs.
  • The success of any vaccination program depends not only on the immune response generated but also on the quality, safety, and effectiveness of the vaccine produced.
  • The preparation of vaccines involves a series of carefully controlled biological and pharmaceutical processes designed to produce a safe and effective product.
  • Equally important is the standardization of vaccines, which ensures that every batch manufactured meets predefined standards of potency, purity, safety, and stability.

Principles of Vaccination

  • The primary goal of vaccination is to induce active immunity.
  • When vaccine antigens enter the body, they are recognized as foreign substances by immune cells.
  • Antigen-presenting cells process these antigens and present them to lymphocytes, resulting in activation of both humoral and cellular immune responses.

The immune system subsequently develops:

  • Specific antibodies against the pathogen
  • Memory B lymphocytes
  • Memory T lymphocytes

These memory cells enable a rapid and effective response when the individual encounters the actual pathogen in the future.


Types of Vaccines

Vaccines are classified according to the nature of the antigen used.

Live Attenuated Vaccines

  • These vaccines contain live microorganisms that have been weakened under laboratory conditions so that they lose their disease-causing ability while retaining their immunogenic properties.

Characteristics

  • Replicate within the host
  • Produce strong immune responses
  • Often provide long-lasting immunity
  • Usually require fewer booster doses

Examples

  • BCG vaccine
  • Measles vaccine
  • Mumps vaccine
  • Rubella vaccine
  • Oral Polio Vaccine

Inactivated Vaccines

  • These vaccines contain killed microorganisms, either by physical or chemical methods.

Characteristics

  • Cannot multiply in the host
  • Safer for immunocompromised individuals
  • Usually require multiple doses and booster vaccinations

Examples

  • Rabies vaccine
  • Hepatitis A vaccine
  • Inactivated Polio Vaccine

Toxoid Vaccines

  • Certain bacterial diseases are caused primarily by toxins rather than by the microorganisms themselves.
  • These toxins can be chemically detoxified to produce toxoids.

Examples

  • Diphtheria toxoid
  • Tetanus toxoid

Subunit and Recombinant Vaccines

  • These vaccines contain only selected antigenic components of the pathogen rather than the entire organism.

Advantages

  • Improved safety profile
  • Reduced adverse reactions
  • Highly specific immune response

Examples

  • Hepatitis B vaccine
  • Human Papillomavirus vaccine

Preparation of Vaccines

The manufacturing process of vaccines involves several stages designed to ensure the production of a safe and potent immunizing agent.

Selection of the Microorganism

  • The first step involves selecting an appropriate strain of the microorganism capable of inducing protective immunity.

The selected strain should possess:

  • High immunogenicity
  • Genetic stability
  • Safety
  • Ability to produce protective antigens

Master seed lots are established and preserved under controlled conditions to maintain consistency between vaccine batches.


Cultivation and Propagation

  • After selection, the microorganism is propagated in suitable growth systems.

Depending on the vaccine, propagation may occur in:

Cell Culture Systems

  • Widely used for viral vaccines.

Examples include:

  • Vero cells
  • Human diploid cells
  • Chick embryo fibroblasts

Embryonated Eggs

  • Traditionally used for influenza vaccine production.

Bioreactors

  • Large-scale fermenters are used for bacterial vaccine production and recombinant vaccine technology.

This stage aims to generate sufficient quantities of microbial antigen for vaccine manufacture.


Harvesting of Antigen

  • Following propagation, microbial cells or viral particles are collected from the culture medium.

The harvested material may contain:

  • Desired antigen
  • Culture media residues
  • Host cell proteins
  • Cellular debris

Therefore, further purification is necessary.


Attenuation or Inactivation

  • Depending on the type of vaccine, microorganisms undergo attenuation or inactivation.

Attenuation

  • Attenuation involves reducing the virulence of a microorganism while preserving its ability to induce immunity.

Common methods include:

  • Serial passage in cell culture
  • Growth in non-human hosts
  • Genetic modification

Inactivation

Microorganisms are rendered non-infectious using chemical or physical agents such as:

  • Formaldehyde
  • β-Propiolactone
  • Heat

The challenge is to eliminate infectivity while maintaining antigenic integrity.


Purification of Antigens

  • Purification is essential to remove contaminants and improve vaccine safety.

Common purification techniques include:

  • Filtration – Removes particulate contaminants.
  • Centrifugation – Separates antigens based on density.
  • Chromatography – Highly effective for purification of proteins and recombinant antigens.
  • Ultrafiltration – Concentrates antigenic material while removing unwanted molecules.

Purification enhances vaccine quality and minimizes adverse reactions.


Formulation of the Vaccine

  • Purified antigens are combined with additional substances that improve vaccine performance.

Adjuvants

  • Adjuvants enhance the immune response and increase vaccine effectiveness.

Common adjuvants include:

  • Aluminum hydroxide
  • Aluminum phosphate

Stabilizers

  • Stabilizers protect vaccine potency during storage and transportation.

Examples include:

  • Sucrose
  • Lactose
  • Gelatin
  • Amino acids

Preservatives

  • Preservatives prevent microbial contamination in multidose vaccine vials.

Examples include:

  • Thiomersal
  • Phenol

The final formulation is optimized to ensure maximum efficacy and stability.


Filling and Packaging

The formulated vaccine is filled aseptically into sterile containers under strictly controlled manufacturing conditions.

Packaging may involve:

  • Single-dose vials
  • Multidose vials
  • Prefilled syringes

Proper labeling provides information regarding:

  • Batch number
  • Manufacturing date
  • Expiry date
  • Storage conditions

Standardization of Vaccines

  • Standardization refers to the process of ensuring that every vaccine batch consistently meets established quality requirements.
  • Without standardization, variations between vaccine batches could affect safety and effectiveness.

The major objectives are:

  • Ensuring safety
  • Maintaining potency
  • Confirming purity
  • Establishing consistency
  • Guaranteeing stability

Quality Control Tests in Vaccine Standardization

Identity Testing

  • Identity testing confirms that the vaccine contains the intended antigen.

Methods used include:

  • Enzyme-linked immunosorbent assay (ELISA)
  • Polymerase chain reaction (PCR)
  • Immunochemical techniques

Sterility Testing

  • Vaccines must be completely free from contaminating microorganisms.
  • Samples are inoculated into specialized culture media and incubated under controlled conditions.
  • The absence of microbial growth indicates sterility.

Purity Testing

Purity testing evaluates the presence of unwanted contaminants such as:

  • Host cell proteins
  • Residual DNA
  • Culture media components
  • Chemical residues

A highly purified vaccine reduces the risk of adverse reactions.


Potency Testing

  • Potency testing determines whether the vaccine can produce an adequate immune response.
  • It is one of the most important quality control procedures.

Methods include:

  • Antibody response measurement
  • Cell-based immunological assays
  • Animal protection studies

Potency testing ensures that each dose provides sufficient immunological protection.


Safety Testing

  • Safety evaluation is conducted before batch release.

The vaccine is assessed for:

  • Toxicity
  • Pyrogenicity
  • Local tissue reactions
  • Systemic adverse effects

Only vaccines meeting safety standards are approved for use.


Stability Testing

  • Vaccines must retain their potency throughout their shelf life.

Stability studies evaluate vaccine performance under different conditions of:

  • Temperature
  • Humidity
  • Storage duration

The results determine recommended storage conditions and expiry dates.


Cold Chain and Vaccine Storage

  • Vaccines are sensitive biological products whose effectiveness can be compromised by improper storage.
  • The cold chain is a temperature-controlled system that preserves vaccine potency from manufacture to administration.

Most vaccines require storage between: +2°C and +8°C

Breaks in the cold chain can result in irreversible loss of vaccine efficacy, even when the vaccine appears normal.

Maintaining the cold chain is therefore an essential component of successful immunization programs.


Immunization

Immunization is the process by which an individual acquires protection against a disease through stimulation of the immune system or administration of preformed antibodies.

It forms the basis of preventive medicine and public health programs worldwide.

Types of Immunization

Active Immunization

Active immunization occurs when the body’s own immune system produces antibodies and memory cells in response to an antigen.

This may occur through:

  • Natural infection
  • Vaccination

Characteristics

  • Slow onset of protection
  • Long-lasting immunity
  • Development of immunological memory

Passive Immunization

Passive immunization involves the transfer of ready-made antibodies from another source.

Examples

  • Tetanus immunoglobulin
  • Rabies immunoglobulin
  • Anti-snake venom

Characteristics

  • Immediate protection
  • Short duration of immunity
  • No immunological memory

Importance of Immunization

Immunization has transformed global healthcare by preventing millions of deaths annually.

Its major benefits include:

  • Prevention of infectious diseases
  • Reduction in morbidity and mortality
  • Protection of vulnerable populations
  • Reduction of healthcare expenditure
  • Prevention of epidemics and outbreaks
  • Achievement of herd immunity

Widespread vaccination not only protects vaccinated individuals but also reduces transmission within the community.

 

Scroll to Top
Enable Notifications OK No thanks